---
id: 219
title: Empyema (Parapneumonic Effusion)
category: clinical_syndromes
subcategory: respiratory
tags: [empyema, parapneumonic-effusion, pleural-effusion, chest-tube, drainage, Lights-criteria]
difficulty: high
---

## Question

How is empyema managed? Use **"Thoracentesis (pH <7.2, Glucose <60, LDH >1000) → Chest Tube Drainage + Antibiotics × 3-6 Weeks"** framework.

## Answer

### **Classification:**

**Parapneumonic Effusion (PPE):**
- **Pleural effusion** associated with pneumonia, lung abscess, or bronchiectasis
- **30-40% of hospitalized pneumonia** develop PPE

**Empyema:**
- **Pus in pleural space** (frank pus or positive Gram stain/culture)

**Stages:**

**Stage 1 (Exudative, Simple PPE):**
- **Sterile, thin fluid**
- **pH >7.2, glucose >60 mg/dL, LDH <1000 IU/L**
- **Treatment:** Antibiotics alone

**Stage 2 (Fibrinopurulent, Complicated PPE):**
- **Bacterial invasion** (Gram stain/culture may be positive)
- **pH <7.2, glucose <60 mg/dL, LDH >1000 IU/L**
- **Loculations forming**
- **Treatment:** Chest tube drainage + antibiotics

**Stage 3 (Organizing, Chronic Empyema):**
- **Thick fibrous peel** (lung entrapment)
- **Organized loculations**
- **Treatment:** Surgical decortication (VATS or open thoracotomy)

### **Diagnosis:**

**Imaging:**
- **Chest X-ray:** Layering effusion, obscured costophrenic angle
- **Ultrasound:** Detects loculations, septations, guides thoracentesis
- **CT chest with contrast:** Delineates loculations, "split pleura sign" (visceral + parietal pleura enhance)

**Thoracentesis (ESSENTIAL):**

**Send Pleural Fluid for:**
- **Cell count with differential**
- **Gram stain, aerobic/anaerobic culture**
- **pH, glucose, LDH, protein**
- **Cytology** (r/o malignancy)

**Light's Criteria (Exudate vs Transudate):**

**Exudate (≥1 of):**
- Pleural protein / serum protein >0.5
- Pleural LDH / serum LDH >0.6
- Pleural LDH >2/3 upper limit of normal serum LDH

**Complicated PPE/Empyema Criteria (Drainage Indicated):**
- **Frank pus** (gross appearance)
- **Positive Gram stain or culture**
- **pH <7.2**
- **Glucose <60 mg/dL**
- **LDH >1000 IU/L**
- **Large effusion** (>50% hemithorax)
- **Loculated**

### **Microbiology:**

**Community-Acquired:**
- ***Streptococcus pneumoniae*, *S. pyogenes*, *S. milleri* group**
- ***Staphylococcus aureus***
- **Anaerobes** (*Fusobacterium*, *Prevotella*, *Peptostreptococcus*) - if aspiration

**Hospital-Acquired/Post-Operative:**
- ***S. aureus* (MSSA/MRSA)**
- **Gram-negatives** (*E. coli*, *Klebsiella*, *Pseudomonas*)
- **Anaerobes**

**Aspiration:**
- **Anaerobes** (foul-smelling pus)

### **Treatment:**

**1. Antibiotics (Prolonged):**

**Empiric (Community-Acquired):**
- **Ceftriaxone 2g IV daily + metronidazole 500mg IV q8h**
- OR **ampicillin-sulbactam 3g IV q6h**
- OR **pip-tazo 3.375-4.5g IV q6-8h**

**Empiric (Hospital-Acquired, Post-Surgical):**
- **Vancomycin 15-20 mg/kg IV q8-12h + pip-tazo 4.5g IV q6h**
- OR **vancomycin + meropenem 1g IV q8h**

**Pathogen-Directed:**
- **Narrow based on culture/susceptibilities**

**Duration:**
- **3-6 weeks** (total)
- **Switch to oral** once afebrile, clinically improved, effusion resolving
- **Longer if:** Slow response, inadequate drainage, immunocompromised

**2. Drainage (If Complicated PPE/Empyema):**

**Chest Tube (First-Line):**
- **Large-bore (≥28 Fr)** or **small-bore (10-14 Fr) with fibrinolytics**
- **Place until:** Drainage <50 mL/day + clinical improvement + CXR improvement

**Fibrinolytics (If Loculated):**
- **tPA 10 mg + DNase 5 mg intrapleural BID × 3 days** (MIST2 protocol)
- **Improves drainage, reduces surgery need**

**Indications for Surgery:**

**VATS (Video-Assisted Thoracoscopic Surgery):**
- **Failed chest tube drainage** (persistent fever, loculations)
- **Stage 2-3 empyema** (organized, thick peel)

**Open Thoracotomy (Decortication):**
- **Chronic empyema** (stage 3, thick peel, lung entrapment)
- **Failed VATS**

**3. Supportive Care:**
- **IV fluids, nutrition**
- **Incentive spirometry, pulmonary toilet**

### **Monitoring:**

**Clinical Improvement:**
- **Afebrile within 3-5 days**
- **Decreased WBC, CRP**
- **Chest tube output decreasing**

**Imaging:**
- **Serial CXR** (assess effusion resolution)
- **CT if no improvement** (r/o loculations, abscess)

**Remove Chest Tube When:**
- **Drainage <50-100 mL/day**
- **Fluid clear** (not purulent)
- **CXR improved**

### **Prognosis:**

**Mortality:** 5-20% (higher if elderly, comorbidities, delayed drainage)

**Predictors of Poor Outcome:**
- **Delayed drainage** (>3 days after diagnosis)
- **Hospital-acquired empyema**
- **Elderly, comorbidities** (diabetes, COPD, malignancy)
- ***S. aureus*, Gram-negatives**

## Key Points

### **Thoracentesis = Diagnostic:**
- **pH <7.2, glucose <60, LDH >1000** → drainage indicated
- **Frank pus, positive Gram stain/culture** → empyema

### **Chest Tube + Antibiotics:**
- **Drainage = PRIMARY** (chest tube, VATS if loculated/failed)
- **Antibiotics × 3-6 weeks**

### **Fibrinolytics if Loculated:**
- **tPA 10 mg + DNase 5 mg intrapleural BID × 3 days** (MIST2)
- **Reduces surgery need**

### **Surgery if Failed Medical Management:**
- **VATS** (stage 2-3, loculated)
- **Decortication** (chronic empyema, thick peel)

### **Prolonged Antibiotics:**
- **3-6 weeks** (IV initially, switch to oral when improved)

### **Clinical Pearls:**
- **Thoracentesis:** pH <7.2, glucose <60, LDH >1000 → drainage indicated
- **Chest tube + antibiotics × 3-6 weeks**
- **Fibrinolytics:** tPA + DNase intrapleural (if loculated)
- **Surgery (VATS/decortication):** If failed chest tube, chronic empyema
- **Empiric:** Ceftriaxone + metronidazole OR pip-tazo (cover Strep, anaerobes)
- **Delayed drainage** = worse outcomes

## Sources

- [IDSA/ATS: Parapneumonic Effusion/Empyema Guidelines 2024]
- [NEJM: Management of Pleural Effusion 2024]

## Media

N/A
